Navigation Links
IMD Companies, Inc. (ICBU) Announces Procedure for Issuance of Positive Solutions Stock
Date:2/7/2013

TAMPA, Fla., Feb. 7, 2013 /PRNewswire/ -- IMD Companies, Inc. (ICBU) announces that it has published the procedure for the issuance of Positive Solutions Inc. on the company's websites.  All shareholders of record of ICBU stock on August 17, 2012, will receive one share of Positive stock for every two shares of ICBU stock held.

The shares of Positive Solutions, a privately held Florida corporation, were issued to ICBU in exchange for the spin-off of the subsidiary last June. ICBU's Board of Directors approved a resolution to issue the shares on a one for two basis. Positive Solutions has been engaged in negotiations for potential acquisitions with various medical and non-medical companies as a platform to expand its activities in the industry, and is hopeful that a completed merger can be announced currently. "We are hopeful that these shares will represent a valuable asset not only for ICBU going forward, but for our shareholders that received the issuance as well," stated ICBU CEO Bruce Collette .

ABOUT IMD Companies, Inc.

IMD Companies, Inc., (OTC MARKETS:ICBU) is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. Its primary products and services lie in the health and fitness nutraceutical and medical diagnostics services markets. The company has also expanded into the weight-loss industry.  The company delivers its medical diagnostic services on-site at participating medical clinics and physician offices. The nutraceutical supplements, pills, bar and gels will be marketed and distributed through participating clinics and on-line web marketing retail methods.  The company will continue to develop its innovative marketing strategies, including the use of social networking vehicles.

Safe Harbor Statement:

Certain statements made in this press release constit
'/>"/>

SOURCE IMD Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
2. Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
3. IMD Companies, Inc. (ICBU) looks to future and adapts
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015 Konica Minolta Medical Imaging ... (CR) system, designed to deliver enterprise level imaging to ... same Control Station as the Konica Minolta AeroDR wireless ... upgrade path from CR to DR. The SIGMA II ... improve workflow with unparalleled reliability and high capacity to ...
(Date:9/1/2015)... Sept. 1, 2015 Sleep Specialists, LLC ... and HGE Health Care Solutions, a leader in ... a comprehensive sleep management and cost reduction program ... OSA is a chronic medical condition characterized ... may increase a patient,s risk for cardiovascular disease, ...
(Date:9/1/2015)... Conn. , Sept. 1, 2015  Results from ... AD™ study demonstrate that 5g of idarucizumab enabled ... situations involving patients treated with dabigatran (Pradaxa ® ... of the anticoagulant effect of dabigatran enabled patients ... a median time of 1.7 hours between administration ...
Breaking Medicine Technology:Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9
... prGCD treatment of Gaucher Disease, CARMIEL, Israel, Aug. ... announced that it has treated the,first patient in its ... prGCD, a proprietary plant cell expressed recombinant form of,human ... storage disorder in humans. The phase III clinical ...
... Acute, Radiation Syndrome or Radiotherapy Adjuvant Likely Targeting Adult ... ... SCOTTSDALE, Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a wholly ... today announced that initial studies at,TD2 (TGen Drug Development Services), ...
Cached Medicine Technology:Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4
(Date:9/2/2015)... ... , ... “ G-Hold ” was featured on NewsWatch as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... tablet while reducing the likelihood of it dropping. , Tablets like the iPad and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Pentec Health, Inc., a national ... List for an impressive sixth consecutive year. Less than 5 % of this year’s ... in the “health” sector. Pentec’s 3-year revenue growth rate of 65% sustained its ...
(Date:9/2/2015)... ... September 02, 2015 , ... Mobile working is increasingly more important, as business ... everywhere new mobile apps are being launched, and mobile device usage as a whole ... of their work and personal lives. What's more people are expecting mobile versions of ...
(Date:9/1/2015)... ... September 01, 2015 , ... For many men, the first thing they notice when ... often forced to wear a looser fitting shirt with a collar that doesn’t close against ... finger between their collar and skin all day because it’s uncomfortable. Now men in ...
(Date:9/1/2015)... ... September 02, 2015 , ... The Journal of ... of life, in the USA ”. , As corresponding author Mr Christopher Malone says ... States. In our study, we endeavoured to better understand how migraine headaches impact the ...
Breaking Medicine News(10 mins):Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... England star David Beckham is craving for pie and mash, and ... The Scotsman, Becks recently confessed to being homesick following his move ... to be shown on Tuesday at 9 p.m., Becks admits: "Obviously, ... also miss things like English pubs. I will also miss pie ...
... Jordanians and Iraqis, will face prejudice in the wake of ... and Glasgow. ,According to the medical journal ... as an excuse to discriminate against overseas doctors who are ... ,According to a report in the BBC, ...
... research has revealed that four percent of American youths online ... themselves over the Internet. ,Researchers at the ... found that one in 25 youth who use the Internet ... themselves during the course of the year. ,This ...
... Ayurveda, a native system of medicine, has been sentenced to ... for causing the death of a pregnant woman who sought ... ago. ,The doctor had administered some medicines to ... ,According to the prosecution, the deceased, Babli had ...
... Oscar-winning actress Hilary Swank will soon be seen in action spearheading ... their hair as a result of cancer treatment. ... locks, get it cut, and donate it for making wigs for ... ,Swank, who joins the campaign from 2008, will donate her ...
... all right but sans glamorous clothes, high heels and ... women's contest with the aim of reducing infant ... evaluates mothers' weights during pregnancy, the kind of medication ... home. ,The criteria are evaluated by a ...
Cached Medicine News:Health News:Indian, Iraqi Medics may Face Terror Stigma Overseas 2Health News:Four Percent of American Youths are Requested to Post Sexual Snaps on Web 2Health News:Pregnant Women's Contest to Curb Infant Mortality 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: